Platelet antistaphylococcal responses occur through P2X1 and P2Y12 receptor-induced activation and kinocidin release

Infection and Immunity

Volumn 76, Issue 12, 2008, Pages 5706-5713

  Trier, Darin A ^a   Gank, Kimberly D ^a   Kupferwasser, Deborah ^a   Yount, Nannette Y ^a   French, William J ^a   Michelson, Alan D ^c   Kupferwasser, Leon I ^a,d   Xiong, Yan Q ^a,b   Bayer, Arnold S ^a,b   Yeaman, Michael R ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; APYRASE; CANGRELOR; CHEMOKINE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB ALPHA; MICROBICIDE; PADGEM PROTEIN; PHOSPHOLIPASE C INHIBITOR; PLATELET KINOCIDIN; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; SURAMIN; THROMBOCYTE FACTOR; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIABILITY; DEGRANULATION; GENE AMPLIFICATION; HOST RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE RELEASE REACTION;

ANIMALS; BLOOD PLATELETS; CHEMOKINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; PLATELET ACTIVATION; RABBITS; RECEPTORS, PURINERGIC P2; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 57349102283     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00935-08     Document Type: Article

References (47)

1. Azizi, N., C. Li, A. J. Shen, A. S. Bayer, and M. R. Yeaman. 1996. Staphylococcus aureus elicits release of platelet microbicidal proteins in vitro, abstr. 866. Abstr. 36th Intersci. Conf. Antimicrob. Agents Chemother., New Orleans, LA. American Society for Microbiology, Washington, DC.
2. Bayer, A. S., P. McNamara, M. R. Yeaman, N. Lucindo, T. Jones, A. L. Cheung, H. G. Sahl, and R. A. Proctor. 2006. Transposon disruption of the complex I NADH oxidoreductase gene (snoD) in Staphylococcus aureus is associated with reduced susceptibility to the microbicidal activity of thrombin-induced platelet microbicidal protein 1. J. Bacteriol. 188:211-222.
3. Bayer, A. S., P. M. Sullam, M. Ramos, C. Li, A. L. Cheung, and M. R. Yeaman. 1995. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains. Infect. Immun. 63:3634-3641.
4. Cattaneo, M. 2007. The platelet P2 receptors, p. 201-220. In A. D. Michelson (ed.), Platelets, 2nd ed. Elsevier Science, New York, NY.
5. Chang, F. Y., N. Singh, T. Gayowski, M. M. Wagener, S. M. Mietzner, J. E. Stout, and I. R. Marino. 2000. Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation 69:70-75.
6. Clawson, C. C. 1973. Platelet interaction with bacteria. 3. Ultrastructure. Am. J. Pathol. 70:449-471.
7. Clawson, C. C., G. H. Rao, and J. G. White. 1975. Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am. J. Pathol. 81:411-420.
8. Clawson, C. C., and J. G. White. 1971. Platelet interaction with bacteria. I. Reaction phases and effects of inhibitors. Am. J. Pathol. 65:367-380.
9. Clawson, C. C., and J. G. White. 1971. Platelet interaction with bacteria. II. Fate of the bacteria. Am. J. Pathol. 65:381-397.
10. Cosgrove, S. E., and V. G. Fowler, Jr. 2008. Management of methicillin-resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 46(Suppl. 5):S386-S393.
11. Dhawan, V. K., M. R. Yeaman, A. L. Cheung, E. Kim, P. M. Sullam, and A. S. Bayer. 1997. Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus. Infect. Immun. 65:3293-3299.
12. Feldman, C., J. M. Kallenbach, H. Levy, J. R. Thorburn, M. D. Hurwitz, and H. J. Koornhof. 1991. Comparison of bacteraemic community-acquired lobar pneumonia due to Streptococcus pneumoniae and Klebsiella pneumoniae in an intensive care unit. Respiration 58:265-270.
13. Fu, Y., K. Gank, D. Kupferwasser, N. Yount, H. Park, J. E. Edwards, Jr., S. G. Filler, and M. R. Yeaman. 2005. Abstr. 105th Gen. Meet. Am. Soc. Microbiol., Atlanta, GA, abstr. F-061. American Society for Microbiology, Washington, DC.
14. Hallam, T. J., and T. J. Rink. 1985. Agonists stimulate divalent cation channels in the plasma membrane of human platelets. FEBS Lett. 186:175-179.
15. Hallam, T. J., and T. J. Rink. 1985. Responses to adenosine diphosphate in human platelets loaded with the fluorescent calcium indicator quin2. J. Physiol. 368:131-146.
16. Hawiger, J., S. Steckley, D. Hammond, C. Cheng, S. Timmons, A. D. Glick, and R. M. Des Prez. 1979. Staphylococci-induced human platelet injury mediated by protein A and immunoglobulin G Fc fragment receptor. J. Clin. Investig. 64:931-937.
17. 2+-ATPase in calcium responses of single, fibrinogen-bound platelets. J. Biol. Chem. 268:356-363.
18. Herrmann, M., S. J. Suchard, L. A. Boxer, F. A. Waldvogel, and P. D. Lew. 1991. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect. Immun. 59:279-288.
19. Hollopeter, G., H. M. Jantzen, D. Vincent, G. Li, L. England, V. Ramakrishnan, R. B. Yang, P. Nurden, A. Nurden, D. Julius, and P. B. Conley. 2001. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409:202-207.
20. Hourani, S. M., and N. J. Cusack. 1991. Pharmacological receptors on blood platelets. Pharmacol. Rev. 43:243-298.
21. Jin, J., J. L. Daniel, and S. P. Kunapuli. 1998. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J. Biol. Chem. 273:2030-2034.
22. 3and ADP receptors. Blood 99:193-198.
23. Klinger, M. H., and W. Jelkmann. 2002. Role of blood platelets in infection and inflammation. J. Interferon Cytokine Res. 22:913-922.
24. Kupferwasser, L. I., M. R. Yeaman, S. M. Shapiro, C. C. Nast, and A. S. Bayer. 2002. In vitro susceptibility to thrombin-induced platelet microbicidal protein is associated with reduced disease progression and complication rates in experimental Staphylococcus aureus endocarditis: microbiological, histopathologic, and echocardiographic analyses. Circulation 105:746-752.
25. Lipsky, P. E. 1999. Role of cyclooxygenase-1 and -2 in health and disease. Am. J. Orthop. (Belle Mead, NJ) 28:8-12.
26. Mercier, R. C., M. J. Rybak, A. S. Bayer, and M. R. Yeaman. 2000. Influence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditis. Infect. Immun. 68:4699-4705.
27. Niemann, S., N. Spehr, H. Van Aken, E. Morgenstern, G. Peters, M. Herrmann, and B. E. Kehrel. 2004. Soluble fibrin is the main mediator of Staphylococcus aureus adhesion to platelets. Circulation 110:193-200.
28. Parise, L. V., S. S. Smythe, and B. Coller. 2005. Platelet morphology, biochemistry and function, p. 1357-1409. In E. Beutler, M. A. Lichtman, B. S. Coller, T. J. Kipps, and U. Seligsohn (ed.), Williams hematology, 7th ed. McGraw-Hill, New York, NY.
29. Quinton, T. M., S. Murugappan, S. Kim, J. Jin, and S. P. Kunapuli. 2004. Different G protein-coupled signaling pathways are involved in alpha granule release from human platelets. J. Thromb. Haemost. 2:978-984.
30. Ryan, D. H. 2005. Examination of the blood, p. 9-17. In E. Beutler, M. A. Lichtman, B. S. Coller, T. J. Kipps, and U. Seligsohn (ed.), Williams hematology, 7th ed. McGraw-Hill, New York, NY.
31. Sage, S. O., A. B. MacKenzie, S. Jenner, and M. P. Mahaut-Smith. 1997. Purinoceptor-evoked calcium signalling in human platelets. Prostaglandins Leukot. Essent. Fatty Acids 57:435-438.
32. Siboo, I. R., A. L. Cheung, A. S. Bayer, and P. M. Sullam. 2001. Clumping factor A mediates binding of Staphylococcus aureus to human platelets. Infect. Immun. 69:3120-3127.
33. Sullam, P. M., U. Frank, M. R. Yeaman, M. G. Tauber, A. S. Bayer, and H. F. Chambers. 1993. Effect of thrombocytopenia on the early course of streptococcal endocarditis. J. Infect. Dis. 168:910-914.
34. Tang, Y. Q., M. R. Yeaman, and M. E. Selsted. 2002. Antimicrobial peptides from human platelets. Infect. Immun. 70:6524-6533.
35. Viscoli, C., P. Bruzzi, E. Castagnola, L. Boni, T. Calandra, H. Gaya, F. Meunier, R. Feld, S. Zinner, J. Klastersky, et al. 1994. Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. Eur. J. Cancer 30A:430-437.
36. Xiong, Y. Q., A. S. Bayer, and M. R. Yeaman. 2002. Inhibition of intracellular macromolecular synthesis in Staphylococcus aureus by thrombin-induced platelet microbicidal proteins. J. Infect. Dis. 185:348-356.
37. Yeaman, M. R. 1997. The role of platelets in antimicrobial host defense. Clin. Infect. Dis. 25:951-970.
38. Yeaman, M. R., and A. S. Bayer. 2007. Antimicrobial host defense, p. 727-755. In A. D. Michelson (ed.), Platelets, 2nd ed. Elsevier Science, New York, NY.
39. Yeaman, M. R., K. D. Gank, A. S. Bayer, and E. P. Brass. 2002. Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices. Antimicrob. Agents Chemother. 46:3883-3891.
40. Yeaman, M. R., S. M. Puentes, D. C. Norman, and A. S. Bayer. 1992. Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein. Infect. Immun. 60:1202-1209.
41. Yeaman, M. R., P. M. Sullam, P. F. Dazin, D. C. Norman, and A. S. Bayer. 1992. Characterization of Staphylococcus aureus-platelet binding by quantitative flow cytometric analysis. J. Infect. Dis. 166:65-73.
42. Yeaman, M. R., Y. Q. Tang, A. J. Shen, A. S. Bayer, and M. E. Selsted. 1997. Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect. Immun. 65:1023-1031.
43. Yeaman, M. R., and N. Yount. 2005. Code among chaos: immunorelativity and the AEGIS model of antimicrobial peptides. ASM News 71:21-27.
44. Yeaman, M. R., and N. Y. Yount. 2007. Unifying themes in host defence effector polypeptides. Nat. Rev. 5:727-740.
45. Yeaman, M. R., N. Y. Yount, A. J. Waring, K. D. Gank, D. Kupferwasser, R. Wiese, A. S. Bayer, and W. H. Welch. 2007. Modular determinants of antimicrobial activity in platelet factor-4 family kinocidins. Biochim. Biophys. Acta 1768:609-619.
46. Yount, N. Y., K. D. Gank, Y. Q. Xiong, A. S. Bayer, T. Pender, W. H. Welch, and M. R. Yeaman. 2004. Platelet microbicidal protein 1: structural themes of a multifunctional antimicrobial peptide. Antimicrob. Agents Chemother. 48:4395-4404.
47. Youssefian, T., A. Drouin, J. M. Masse, J. Guichard, and E. M. Cramer. 2002. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 99:4021-4029.